Jupiter Asset Management Ltd. Makes New $2.44 Million Investment in Alignment Healthcare, Inc. $ALHC

Jupiter Asset Management Ltd. bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 174,084 shares of the company’s stock, valued at approximately $2,437,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Ballentine Partners LLC lifted its holdings in shares of Alignment Healthcare by 8.6% in the 1st quarter. Ballentine Partners LLC now owns 11,674 shares of the company’s stock valued at $217,000 after purchasing an additional 924 shares during the last quarter. MCF Advisors LLC lifted its holdings in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after acquiring an additional 1,011 shares during the period. Cresset Asset Management LLC boosted its holdings in Alignment Healthcare by 0.6% during the first quarter. Cresset Asset Management LLC now owns 287,565 shares of the company’s stock worth $5,354,000 after buying an additional 1,797 shares in the last quarter. Signaturefd LLC grew its holdings in shares of Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ acquired a new stake in Alignment Healthcare in the first quarter valued at $42,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Insider Activity at Alignment Healthcare

In related news, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the firm’s stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total transaction of $99,999,996.96. Following the transaction, the director owned 24,596,079 shares in the company, valued at $393,783,224.79. This trade represents a 20.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John E. Kao sold 355,018 shares of the business’s stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $5,825,845.38. Following the completion of the sale, the chief executive officer directly owned 4,533,568 shares in the company, valued at $74,395,850.88. This represents a 7.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 7,593,948 shares of company stock worth $122,396,905 in the last ninety days. 7.00% of the stock is currently owned by corporate insiders.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $16.77 on Friday. Alignment Healthcare, Inc. has a 52 week low of $10.18 and a 52 week high of $21.06. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The business has a 50 day moving average of $16.97 and a two-hundred day moving average of $15.43. The company has a market cap of $3.36 billion, a P/E ratio of -139.75 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The company had revenue of $993.70 million for the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The firm’s quarterly revenue was up 43.5% compared to the same quarter last year. During the same period last year, the business posted ($0.14) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on ALHC. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. UBS Group increased their price target on shares of Alignment Healthcare from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price for the company in a research report on Monday, August 25th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $22.00 target price on shares of Alignment Healthcare in a research note on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.85.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.